Magtera

Magtera is a preclinical-stage biotechnology company pioneering the field of magneto-genetics to enable remote, non-invasive control of biological functions. The company develops engineered proteins and cellular systems that can be activated or modulated using external magnetic fields, providing precise spatiotemporal control over therapeutic activity. This platform technology has potential applications across a broad range of therapeutic areas, including metabolic diseases, oncology, and neurology. Magtera aims to transform how medicines are delivered and regulated within the patient's body by replacing systemic drug administration with targeted, field-controlled activation. By leveraging magnetic fields, the company seeks to minimize off-target effects and improve the therapeutic window of potent biologics.